By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GW Pharmaceuticals Ltd. 

Porton Down Science Park

Salisbury  Wiltshire  SP4 0JQ  United Kingdom
Phone: 44-1980-619000 Fax: +44-1980-619111



Company News
GW Pharmaceuticals To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/26/2014 11:00:53 AM
GW Pharmaceuticals To Report Q4, Year-End 2014 Financial Results And Host Conference Call On 2 December, 2014 11/24/2014 12:56:59 PM
GW Pharmaceuticals To Present At The Jefferies and Co. 2014 Global Healthcare Conference 11/17/2014 4:22:59 PM
GW Pharmaceuticals Commences Phase 2/3 Clinical Trial Of Epidiolex® As A Potential Treatment For Epilepsy In Dravet Syndrome 10/30/2014 7:26:21 AM
GW Pharmaceuticals Announces Epidiolex® Receives Orphan Designation From European Medicines Agency For The Treatment Of Dravet Syndrome 10/22/2014 7:13:35 AM
GW Pharmaceuticals Announces New Physician Reports Of Epidiolex® Treatment Effect In Children And Young Adults With Treatment-Resistant Epilepsy 10/14/2014 9:28:38 AM
Cannabis Biopharma GW Pharmaceuticals Sees Disappointing Data For Colitis Drug 10/14/2014 7:51:11 AM
GW Pharmaceuticals Research And Development Day Details 9/29/2014 11:18:49 AM
GW Pharmaceuticals To Present At The Leerink Rare Disease Roundtable 2014 9/24/2014 7:24:15 AM
GW Pharmaceuticals Reports 2014 Third Quarter Financial Results 8/6/2014 7:55:05 AM